Global API CDMO+CMC Service Platform Supply, Demand and Key Producers, 2024-2030

Publication ID:

GIR032401056

Publication Date:

March 4, 2024

Pages:

124

Publisher:

GIR

Countries:

Global [1]

USD 4,480.00

Software [2]

IT Services [3]

Computing & Electronics [4]

Description:

The global API CDMO+CMC Service Platform market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
The API CDMO+CMC service platform refers to a comprehensive platform that provides pharmaceutical companies with API development and manufacturing services. CDMO stands for Contract Development and Manufacturing Organization (Contract Development and Manufacturing Organization), and CMC stands for Chemistry, Manufacturing, and Controls (Chemistry, Manufacturing, and Controls). manufacturing and control). These platforms cover the entire process from new drug development to commercial production, providing pharmaceutical companies with a package of solutions to help them improve efficiency, reduce costs, and accelerate product launches.
This report studies the global API CDMO+CMC Service Platform demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for API CDMO+CMC Service Platform, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of API CDMO+CMC Service Platform that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global API CDMO+CMC Service Platform total market, 2019-2030, (USD Million)
Global API CDMO+CMC Service Platform total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: API CDMO+CMC Service Platform total market, key domestic companies and share, (USD Million)
Global API CDMO+CMC Service Platform revenue by player and market share 2019-2024, (USD Million)
Global API CDMO+CMC Service Platform total market by Type, CAGR, 2019-2030, (USD Million)
Global API CDMO+CMC Service Platform total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global API CDMO+CMC Service Platform market based on the following parameters 鈥� company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza Group, Catalent, Inc., Thermo Fisher Scientific, Pfizer CentreOne, CordenPharma International, Boehringer Ingelheim BioXcellence, Recipharm AB, Changsha Jingyi Pharmaceutical Technology Co., Ltd. and GlaxoSmithKline, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World API CDMO+CMC Service Platform market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global API CDMO+CMC Service Platform Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global API CDMO+CMC Service Platform Market, Segmentation by Type
Comprehensive CDMO Platform
Professional CDMO Platform
International CDMO Platform
Global API CDMO+CMC Service Platform Market, Segmentation by Application
New Drug Development
Clinical Stage Production
Commercial Production
Companies Profiled:
Lonza Group
Catalent, Inc.
Thermo Fisher Scientific
Pfizer CentreOne
CordenPharma International
Boehringer Ingelheim BioXcellence
Recipharm AB
Changsha Jingyi Pharmaceutical Technology Co., Ltd.
GlaxoSmithKline
Samsung BioLogics
Emergent BioSolutions
Key Questions Answered
1. How big is the global API CDMO+CMC Service Platform market?
2. What is the demand of the global API CDMO+CMC Service Platform market?
3. What is the year over year growth of the global API CDMO+CMC Service Platform market?
4. What is the total value of the global API CDMO+CMC Service Platform market?
5. Who are the major players in the global API CDMO+CMC Service Platform market?

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Supply Summary
1.1 API CDMO+CMC Service Platform Introduction
1.2 World API CDMO+CMC Service Platform Market Size & Forecast (2019 & 2023 & 2030)
1.3 World API CDMO+CMC Service Platform Total Market by Region (by Headquarter Location)
1.3.1 World API CDMO+CMC Service Platform Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States API CDMO+CMC Service Platform Market Size (2019-2030)
1.3.3 China API CDMO+CMC Service Platform Market Size (2019-2030)
1.3.4 Europe API CDMO+CMC Service Platform Market Size (2019-2030)
1.3.5 Japan API CDMO+CMC Service Platform Market Size (2019-2030)
1.3.6 South Korea API CDMO+CMC Service Platform Market Size (2019-2030)
1.3.7 ASEAN API CDMO+CMC Service Platform Market Size (2019-2030)
1.3.8 India API CDMO+CMC Service Platform Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 API CDMO+CMC Service Platform Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 API CDMO+CMC Service Platform Major Market Trends
2 Demand Summary
2.1 World API CDMO+CMC Service Platform Consumption Value (2019-2030)
2.2 World API CDMO+CMC Service Platform Consumption Value by Region
2.2.1 World API CDMO+CMC Service Platform Consumption Value by Region (2019-2024)
2.2.2 World API CDMO+CMC Service Platform Consumption Value Forecast by Region (2025-2030)
2.3 United States API CDMO+CMC Service Platform Consumption Value (2019-2030)
2.4 China API CDMO+CMC Service Platform Consumption Value (2019-2030)
2.5 Europe API CDMO+CMC Service Platform Consumption Value (2019-2030)
2.6 Japan API CDMO+CMC Service Platform Consumption Value (2019-2030)
2.7 South Korea API CDMO+CMC Service Platform Consumption Value (2019-2030)
2.8 ASEAN API CDMO+CMC Service Platform Consumption Value (2019-2030)
2.9 India API CDMO+CMC Service Platform Consumption Value (2019-2030)
3 World API CDMO+CMC Service Platform Companies Competitive Analysis
3.1 World API CDMO+CMC Service Platform Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global API CDMO+CMC Service Platform Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for API CDMO+CMC Service Platform in 2023
3.2.3 Global Concentration Ratios (CR8) for API CDMO+CMC Service Platform in 2023
3.3 API CDMO+CMC Service Platform Company Evaluation Quadrant
3.4 API CDMO+CMC Service Platform Market: Overall Company Footprint Analysis
3.4.1 API CDMO+CMC Service Platform Market: Region Footprint
3.4.2 API CDMO+CMC Service Platform Market: Company Product Type Footprint
3.4.3 API CDMO+CMC Service Platform Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: API CDMO+CMC Service Platform Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: API CDMO+CMC Service Platform Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: API CDMO+CMC Service Platform Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: API CDMO+CMC Service Platform Consumption Value Comparison
4.2.1 United States VS China: API CDMO+CMC Service Platform Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: API CDMO+CMC Service Platform Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based API CDMO+CMC Service Platform Companies and Market Share, 2019-2024
4.3.1 United States Based API CDMO+CMC Service Platform Companies, Headquarters (States, Country)
4.3.2 United States Based Companies API CDMO+CMC Service Platform Revenue, (2019-2024)
4.4 China Based Companies API CDMO+CMC Service Platform Revenue and Market Share, 2019-2024
4.4.1 China Based API CDMO+CMC Service Platform Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies API CDMO+CMC Service Platform Revenue, (2019-2024)
4.5 Rest of World Based API CDMO+CMC Service Platform Companies and Market Share, 2019-2024
4.5.1 Rest of World Based API CDMO+CMC Service Platform Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies API CDMO+CMC Service Platform Revenue, (2019-2024)
5 Market Analysis by Type
5.1 World API CDMO+CMC Service Platform Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Comprehensive CDMO Platform
5.2.2 Professional CDMO Platform
5.2.3 International CDMO Platform
5.3 Market Segment by Type
5.3.1 World API CDMO+CMC Service Platform Market Size by Type (2019-2024)
5.3.2 World API CDMO+CMC Service Platform Market Size by Type (2025-2030)
5.3.3 World API CDMO+CMC Service Platform Market Size Market Share by Type (2019-2030)
6 Market Analysis by Application
6.1 World API CDMO+CMC Service Platform Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 New Drug Development
6.2.2 Clinical Stage Production
6.2.3 Commercial Production
6.3 Market Segment by Application
6.3.1 World API CDMO+CMC Service Platform Market Size by Application (2019-2024)
6.3.2 World API CDMO+CMC Service Platform Market Size by Application (2025-2030)
6.3.3 World API CDMO+CMC Service Platform Market Size by Application (2019-2030)
7 Company Profiles
7.1 Lonza Group
7.1.1 Lonza Group Details
7.1.2 Lonza Group Major Business
7.1.3 Lonza Group API CDMO+CMC Service Platform Product and Services
7.1.4 Lonza Group API CDMO+CMC Service Platform Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Lonza Group Recent Developments/Updates
7.1.6 Lonza Group Competitive Strengths & Weaknesses
7.2 Catalent, Inc.
7.2.1 Catalent, Inc. Details
7.2.2 Catalent, Inc. Major Business
7.2.3 Catalent, Inc. API CDMO+CMC Service Platform Product and Services
7.2.4 Catalent, Inc. API CDMO+CMC Service Platform Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Catalent, Inc. Recent Developments/Updates
7.2.6 Catalent, Inc. Competitive Strengths & Weaknesses
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Details
7.3.2 Thermo Fisher Scientific Major Business
7.3.3 Thermo Fisher Scientific API CDMO+CMC Service Platform Product and Services
7.3.4 Thermo Fisher Scientific API CDMO+CMC Service Platform Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Thermo Fisher Scientific Recent Developments/Updates
7.3.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.4 Pfizer CentreOne
7.4.1 Pfizer CentreOne Details
7.4.2 Pfizer CentreOne Major Business
7.4.3 Pfizer CentreOne API CDMO+CMC Service Platform Product and Services
7.4.4 Pfizer CentreOne API CDMO+CMC Service Platform Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Pfizer CentreOne Recent Developments/Updates
7.4.6 Pfizer CentreOne Competitive Strengths & Weaknesses
7.5 CordenPharma International
7.5.1 CordenPharma International Details
7.5.2 CordenPharma International Major Business
7.5.3 CordenPharma International API CDMO+CMC Service Platform Product and Services
7.5.4 CordenPharma International API CDMO+CMC Service Platform Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 CordenPharma International Recent Developments/Updates
7.5.6 CordenPharma International Competitive Strengths & Weaknesses
7.6 Boehringer Ingelheim BioXcellence
7.6.1 Boehringer Ingelheim BioXcellence Details
7.6.2 Boehringer Ingelheim BioXcellence Major Business
7.6.3 Boehringer Ingelheim BioXcellence API CDMO+CMC Service Platform Product and Services
7.6.4 Boehringer Ingelheim BioXcellence API CDMO+CMC Service Platform Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Boehringer Ingelheim BioXcellence Recent Developments/Updates
7.6.6 Boehringer Ingelheim BioXcellence Competitive Strengths & Weaknesses
7.7 Recipharm AB
7.7.1 Recipharm AB Details
7.7.2 Recipharm AB Major Business
7.7.3 Recipharm AB API CDMO+CMC Service Platform Product and Services
7.7.4 Recipharm AB API CDMO+CMC Service Platform Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Recipharm AB Recent Developments/Updates
7.7.6 Recipharm AB Competitive Strengths & Weaknesses
7.8 Changsha Jingyi Pharmaceutical Technology Co., Ltd.
7.8.1 Changsha Jingyi Pharmaceutical Technology Co., Ltd. Details
7.8.2 Changsha Jingyi Pharmaceutical Technology Co., Ltd. Major Business
7.8.3 Changsha Jingyi Pharmaceutical Technology Co., Ltd. API CDMO+CMC Service Platform Product and Services
7.8.4 Changsha Jingyi Pharmaceutical Technology Co., Ltd. API CDMO+CMC Service Platform Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Changsha Jingyi Pharmaceutical Technology Co., Ltd. Recent Developments/Updates
7.8.6 Changsha Jingyi Pharmaceutical Technology Co., Ltd. Competitive Strengths & Weaknesses
7.9 GlaxoSmithKline
7.9.1 GlaxoSmithKline Details
7.9.2 GlaxoSmithKline Major Business
7.9.3 GlaxoSmithKline API CDMO+CMC Service Platform Product and Services
7.9.4 GlaxoSmithKline API CDMO+CMC Service Platform Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 GlaxoSmithKline Recent Developments/Updates
7.9.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.10 Samsung BioLogics
7.10.1 Samsung BioLogics Details
7.10.2 Samsung BioLogics Major Business
7.10.3 Samsung BioLogics API CDMO+CMC Service Platform Product and Services
7.10.4 Samsung BioLogics API CDMO+CMC Service Platform Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 Samsung BioLogics Recent Developments/Updates
7.10.6 Samsung BioLogics Competitive Strengths & Weaknesses
7.11 Emergent BioSolutions
7.11.1 Emergent BioSolutions Details
7.11.2 Emergent BioSolutions Major Business
7.11.3 Emergent BioSolutions API CDMO+CMC Service Platform Product and Services
7.11.4 Emergent BioSolutions API CDMO+CMC Service Platform Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 Emergent BioSolutions Recent Developments/Updates
7.11.6 Emergent BioSolutions Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 API CDMO+CMC Service Platform Industry Chain
8.2 API CDMO+CMC Service Platform Upstream Analysis
8.3 API CDMO+CMC Service Platform Midstream Analysis
8.4 API CDMO+CMC Service Platform Downstream Analysis
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

Companies Mentioned:

Lonza Group
Catalent, Inc.
Thermo Fisher Scientific
Pfizer CentreOne
CordenPharma International
Boehringer Ingelheim BioXcellence
Recipharm AB
Changsha Jingyi Pharmaceutical Technology Co., Ltd.
GlaxoSmithKline
Samsung BioLogics
Emergent BioSolutions

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂